SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Overdose Reversal 
Medication Act’’ or the ‘‘ORM Act’’. 
SEC. 2. OPIOID OVERDOSE REVERSAL DRUG STANDARD. 
(a) INTERIM FINAL STANDARD.— 
(1) IN GENERAL.—Not later than 1 year after 
the date of enactment of this Act, the Secretary of 
Labor shall issue an interim final standard on work-
place availability of an opioid overdose reversal drug 
or device— 
(A) to require all employers to possess an 
opioid overdose reversal drug or device on site, 
where the required number of doses of such 
drug or device required is determined on the 
basis of the number of employees of the em-
ployer on site, type of occupation, and an as-
sessment of potential use; 
(B) that establishes guidelines for training 
on— 
(i) identifying signs and symptoms in-
dicating that usage of an opioid overdose 
drug or device is necessary; and 
(ii) how to administer such opioid 
overdose reversal drug or device; and 
(C) that provides for a period as deter-
mined appropriate by the Secretary, not to ex-
VerDate Sep 11 2014 
22:48 Nov 13, 2023
Jkt 049200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H6243.IH
H6243
kjohnson on DSK7ZCZBW3PROD with $$_JOB
ceed 1 year, during which the Secretary shall 
prioritize technical assistance and advice con-
sistent with section 21(d) of the Occupational 
Safety and Health Act of 1970 (29 U.S.C. 
670(d)) to employers subject to the standard 
with respect to compliance with the standard. 
(2) EFFECTIVE
DATE
OF
INTERIM
STAND-
ARD.—The interim final standard shall— 
(A) take effect on a date that is not later 
than 30 days after issuance; 
(B) shall have the same legal effect as an 
occupational safety and health standard as de-
fined by section 3 of the Occupational Safety 
and Health Act of 1970 (29 U.S.C. 652); and 
(C) be in effect until the final standard de-
scribed in subsection (b) becomes effective and 
enforceable. 
(3) FAILURE TO PROMULGATE.—If an interim 
final standard described in paragraph (1) is not 
issued by the date that is 1 year after the date of 
enactment of this Act, the provisions of this Act 
shall be in effect and enforced in the same manner 
and to the same extent as any standard promulgated 
under section 6(b) of the Occupational Safety and 
Health Act (29 U.S.C. 655(b)) until such provisions 
VerDate Sep 11 2014 
22:48 Nov 13, 2023
Jkt 049200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H6243.IH
H6243
kjohnson on DSK7ZCZBW3PROD with $$_JOB
are superseded in whole by an interim final standard 
issued by the Secretary that meets the requirements 
of paragraph (1). 
(b) FINAL STANDARD.—Not later than 2 years after 
the date of enactment of this Act, the Secretary of Labor 
shall, pursuant to section 6 of the Occupational Safety and 
Health Act (29 U.S.C. 655), promulgate a final standard 
on workplace availability of opioid overdose reversal drugs 
or devices— 
(1) for the purposes described in subsection 
(a)(1)(A); 
(2) that shall include, at a minimum, require-
ments contained in the interim final standard pro-
mulgated under subsection (a); and 
(3) be effective and enforceable in the same 
manner and to the same extent as any standard pro-
mulgated under section 6(b) of the Occupational 
Safety and Health Act of 1970 (29 U.S.C. 655(b)). 
(c) DEFINITIONS.—In this section: 
(1) EMPLOYEE; EMPLOYER.—The terms ‘‘em-
ployee’’ and ‘‘employer’’ have the meaning given 
such terms in section 3 of the Occupational Safety 
and Health Act of 1970 (29 U.S.C. 652). 
(2) OPIOID OVERDOSE REVERSAL DRUG OR DE-
VICE.—The term ‘‘opioid overdose reversal drug or 
VerDate Sep 11 2014 
22:48 Nov 13, 2023
Jkt 049200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H6243.IH
H6243
kjohnson on DSK7ZCZBW3PROD with $$_JOB
device’’ means an opioid overdose reversal drug or 
device approved, licensed, cleared, or otherwise au-
thorized for marketing by the Food and Drug Ad-
ministration. 
(3) SECRETARY.—The term ‘‘Secretary’’ means 
the Secretary of Labor. 
SEC. 3. EXPANSION OF THE COMPREHENSIVE OPIOID 
ABUSE GRANT PROGRAM. 
Section 3021 of title I of the Omnibus Crime Control 
and Safe Streets Act of 1968 (34 U.S.C. 10701(a)) is 
amended— 
(1) in subsection (a), by adding at the end the 
following: 
‘‘(11) Developing, implementing, or expanding a 
program (which may include demonstration projects) 
that— 
‘‘(A) provides training on carrying and ad-
ministering an opioid overdose reversal drug or 
device approved, licensed, cleared, or otherwise 
authorized for marketing by the Food and Drug 
Administration for local businesses, individuals, 
or other community entities that are likely to 
encounter individuals with substance use dis-
orders, but are not eligible for other Federal 
grant programs or to receive training or re-
VerDate Sep 11 2014 
22:48 Nov 13, 2023
Jkt 049200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H6243.IH
H6243
kjohnson on DSK7ZCZBW3PROD with $$_JOB
sources under such a grant program related to 
substance use prevention and treatment; or 
‘‘(B) provides resources for employers, in-
dividuals, or community entities described in 
subparagraph (A) who have received training 
described in subparagraph (A) to acquire, 
carry, and administer such a drug or device.’’; 
and 
(2) by adding at the end the following: 
‘‘(g) PREFERENTIAL CONSIDERATION.—In awarding 
grants under this part, the Attorney General may give 
preferential consideration to an application from an appli-
cant in a State that has in effect a law that exempts from 
criminal and civil liability individuals who carry or admin-
ister in good faith an opioid overdose reversal drug or de-
vice approved, licensed, cleared, or otherwise authorized 
for marketing by the Food and Drug Administration, if 
such an individual has been trained to carry or administer 
such drug or device.’’. 
Æ 
VerDate Sep 11 2014 
22:48 Nov 13, 2023
Jkt 049200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6301
E:\BILLS\H6243.IH
H6243
kjohnson on DSK7ZCZBW3PROD with $$_JOB